semaglutide 1 mg dose pen device Ozempic® Dosing Ozempic Injection - Semaglutide Weekly

Taking progress photos under consistent conditions provides more useful feedback than scale weight alone

What makes PlexusDx semaglutide different from Wegovy's 0.25mg starter pen

Prioritize your health and make informed decisions on your weight loss journey.

Julys new data confirm that practices integrating technology are seeing higher patient adherence, better outcomes, and a more scalable approach to care

The Wegovy SmPC advises that semaglutide should be discontinued if pancreatitis is suspected Signs of gallbladder disease including right upper quadrant pain, fever, or jaundice, as GLP-1 receptor agonists and weight loss can increase the risk of gallstones Routine GP consultation is advisable for: Gastrointestinal symptoms persisting beyond 46 weeks without improvement Symptoms significantly impacting quality of life or nutritional intake Unexplained weight loss exceeding expected therapeutic effects New onset of symptoms differing from initial side effects Concerns about symptom severity or medication tolerability NICE guidance on obesity management (TA875) emphasises the importance of regular monitoring during pharmacological weight management interventions